濮阳东方医院看妇科病价格比较低濮阳东方医院做人流很不错,濮阳东方医院看男科评价好收费低,濮阳东方好么,濮阳东方医院做人流价格透明,濮阳东方医院男科治疗早泄口碑比较好,濮阳东方医院男科口碑非常好,濮阳东方妇科医院做人流手术怎么样

ADDIS ABABA, Nov. 15 (Xinhua) -- The African Union (AU) Commission Chairperson Jean Ping on Tuesday met and held talks with a high level Chinese delegation led by Jiang Yaoping, Chinese Vice Minister of Commerce.The discussion between the two sides was mainly focused on the cooperation between China and Africa in different sectors.Ping said AU is ready to do all possible to further strengthen its ties with China.The Chairperson said China has been working in cooperation with AU member states on various areas, including trade, investment, and diplomatic exchanges."We are happy to meet the delegation; a delegation not only as an important partner but as a friend of Africa, a friend with which we are strengthening cooperation constantly," said the Chairperson.He also reiterated that Africa is benefited from the relations with China.He said Africa has established an important relations with China within the China-Africa Cooperation Forum (FOCAC), and the two sides are now engaged in strategic dialogue on very crucial areas.Jiang said that AU has been committed to economic integration in Africa that enable member states improve the livelihoods of Africans.He also said that AU has played a constructive role in meeting global issues like the climate change.The Vice Minister stated that China has become one of the most trading partner of Africa, and the trade volume between China and Africa is increasing from time to time.Leading the delegation, Jiang has also visited the African Union Conference Center (AUCC) Project which is almost completed and is expected to be the avenue of the coming AU Summit for the first time at its own headquarter.

ABU DHABI, Jan. 16 (Xinhua) -- Visiting Chinese Premier Wen Jiabao held talks Monday with UN Secretary General Ban Ki-moon on major international issues.During their talks, Wen said the United Nations had played an indispensable role in boosting international cooperation and coordinated actions among related parties.China supports the UN and the Secretary General to play a bigger role in international affairs and achieve greater success, he said.Chinese Premier Wen Jiabao (L) meets with UN Secretary General Ban Ki-moon (R) in Abu Dhabi, the United Arab Emirates, Jan. 16, 2012.In promoting global sustainable development, the UN and the international community needed to focus on the elimination of poverty, help developing countries properly cope with the difficulties in their drive to transfer to a green economy and provide them with support in such areas as finance, technology and capacity building, Wen said.Ban said China had played an important role in helping attain the UN Millennium Development Goals (MDGs) and settle regional hot issues.Appreciating China's support for the UN, Ban said the United Nations stood ready to advance contacts with China and make concerted efforts to safeguard world peace and promote sustainable development.They also exchanged views on the situation of West Asia and North Africa and other regional issues of common concern.Wen arrived in the capital of the United Arab Emirates Monday morning after concluding an official visit to Saudi Arabia. He visited Nepal on Saturday before flying to the Middle East. The trip will also take him to Qatar.Earlier in the day, the Chinese premier gave a keynote speech at the opening of the 5th World Future Energy Summit.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy to E. coli derived asparaginase and pegapargase chemotherapy drugs used to treat ALL.Acute lymphoblastic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell. White blood cells help the body fight infection and are formed in the bone marrow.Erwinaze is injected directly into the muscle three times a week and works by breaking down one of the body's protein building blocks (the amino acid, asparagine) that is present in the blood, and is necessary for the growth of all cells. Leukemia cells cannot produce this protein building block. When a patient is treated with Erwinaze the leukemia cells die. Normal human cells are able to make enough asparagine for their own needs through biosynthesis and will not be affected by treatment with Erwinaze."The approval of Erwinaze underscores the FDA's commitment to the approval of drugs for conditions with limited patient populations with unmet medical needs using novel trial endpoints," said Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.Side effects associated with Erwinaze treatment include serious allergic reactions, inflammation of the pancreas, high blood levels of liver enzymes, blood clotting, bleeding, nausea, vomiting and high blood sugar.

ISLAMABAD, Nov. 14 (Xinhua) -- Pakistan ranks the seventh in the world in terms of diabetes prevalence rate and over 7.1 million people in the country are diabetes patients, reported local media on Monday.Quoting a report by the World International Diabetes Federation, a local English newspaper "The News" said that every year 89,000 people die of diabetes in Pakistan and the number of diabetes patients in the country could hit 11.5 million by the year 2025 if proper measures were not taken.This would make Pakistan the world's fifth largest country in terms of its number of diabetes patients 14 years later, warned the report.At a seminar organized Monday in Islamabad to observe the World Diabetes Day which falls on Nov. 14, Dr. Abdus Salam from Shifa International Hospital, a private-run hospital in the capital city, said that every ten seconds, two people are diagnosed with diabetes and one person dies of diabetes-related causes.The average age of diabetes patients in Pakistan is one of the lowest in the world, said the report. In a bid to raise public awareness about the harmful effects of diabetes, various diabetes camps, scientific sessions, seminars and walks were organized across the country on Monday to mark the World Diabetes Day.In a message delivered on Sunday, Pakistani Prime Minister Yusuf Raza Gilani said that the World Diabetes Day draws attention to the lethality of the disease and underscores the need of preventive measures at individual and collective levels."Diabetes is a killer which is taking the life of one person out of every 800," said the prime minister, adding that "this disease hits people of all age groups, rich and poor alike without any discrimination."

JIUQUAN, Oct. 26 (Xinhua) -- China will launch the spacecraft Shenzhou-8 in early November at the Jiuquan Satellite Launch Center in northwest deseart area.The unmanned spacecraft is expected to perform China's first space docking with Tiangong-1, or Heavenly Palace-1, a space lab module that was launched in September from the same launch center.The spacecraft and its carrier rocket, an upgraded Long March-2F, were transferred on Wednesday morning on a 20-meter-wide railway to the launch pad.The launch pad is 1,500 meters away from the assembling and testing center. It took nearly two hours to complete the transfer.Technicians completed testing on the assembling of Shenzhou-8 and the rocket after they were delivered to the launch center at the end of August, said Lu Jinrong, the launch center's chief engineer.In the next few days, the launch center will continue testing the spacecraft and the rocket, and inject propellent before the final launch in early November, Lu said.The assembling, testing and transferring of the spacecraft and rocket were all conducted while they were vertical.Shenzhou-8 is capable of docking with the spacecraft Tiangong-1 in both manual and automatic modes.The Tiangong-1 space lab module is functioning smoothly in the orbit, and all equipment and experiments are going well, according to Lu. The module is ready for the docking task, Lu said.